NCT03792841 2025-10-16
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
Amgen
Phase 1 Terminated
Amgen
Baylor College of Medicine
Nova Southeastern University
Ohio State University Comprehensive Cancer Center
Brigham and Women's Hospital